Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-24-000087
Filing Date
2024-04-15
Accepted
2024-04-15 10:55:41
Documents
43
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cncl0415form10k.htm   iXBRL 10-K 360182
2 EXHIBIT 31.1 cncl0415form10kexh31_1.htm EX-31.1 8030
3 EXHIBIT 31.2 cncl0415form10kexh31_2.htm EX-31.2 8007
4 EXHIBIT 32.1 cncl0415form10kexh32_1.htm EX-32.1 3971
10 GRAPHIC auditorheader.jpg GRAPHIC 5115
11 GRAPHIC image_001.jpg GRAPHIC 7596
  Complete submission text file 0001554795-24-000087.txt   1687000

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20231231.xsd EX-101.SCH 15689
6 XBRL CALCULATION FILE cncl-20231231_cal.xml EX-101.CAL 24220
7 XBRL DEFINITION FILE cncl-20231231_def.xml EX-101.DEF 14783
8 XBRL LABEL FILE cncl-20231231_lab.xml EX-101.LAB 119552
9 XBRL PRESENTATION FILE cncl-20231231_pre.xml EX-101.PRE 89291
47 EXTRACTED XBRL INSTANCE DOCUMENT cncl0415form10k_htm.xml XML 110048
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

EIN.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32363 | Film No.: 24843469
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)